Sulphadoxine-Pyrimethamine Therapy in Crohn’s Disease

1 January 1982

journal article
research article
Published by S. Karger AG in Digestion

Vol. 23 (2) , 132-134
https://doi.org/10.1159/000198703

Abstract

A double-blind controlled clinical trial has shown no benefit from the use of sulphadoxine-pyrimethamine over a 12-month period in chronically active Crohn’s disease.

Keywords

MYCOBACTERIA
SULPHADOXINE-PYRIMETHAMINE
CROHNߣS DISEASE